AI-ACCELERATED DRUG DISCOVERY
COMING SOON
AI-accelerated
Drug Discovery for
AI platform for difficult-to-drug molecular targets
|
10% of designed protein-targeting molecules have validated biological activity
10%
Average success rate
Ability to get the hits with characteristics of the leads in one shot
1st
The result from the 1st iteration
Virtual screening of the chemical space with more than a quintillion of diverse molecules
10
Chemical Space
16
Time- and cost-efficient synthesis of novel and diverse molecules
80%
Synthesisabilty
Small Molecule Drug Discovery
Our flexible AI solutions are tailored to identify novel targets and design drug candidates with high success rate in clinical trials
Drug Candidate Success Scoring
Advanced scoring of drug candidate success rate in clinical trials is powered by in-depth experimental data and molecular characteristics analysis
Target Identification
Rapid identification of potential targets navigating in a multiparametric map that embraces all possible relationships of biological entities
Our engine is a robust scientific data processor trained to establish different biological relationships between diseases, proteins, genes and drugs, etc
Receptor AI Knowledge Engine
Platform Benefits
Collaborations & Partnerships
Revolutionize Drug Discovery with our Smart AI Solutions
Pharma Companies
Biotech Companies
Academic Research
Pharmaceutical Investment
Subscribe to Updates
No Spam. Cancel Anytime.
© 2021-2022 RECEPTOR AI | All Rights Reserved.
Cookies managing
Cookie Settings
Cookies necessary for the correct operation of the site are always enabled.
Other cookies are configurable.
Other cookies are configurable.